• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Afr J Thorac Crit Care Med . Comparison of patients with severe COVID-19 admitted to an intensive care unit in South Africa during the first and sec

tetano

Editor, Senior Moderator
Afr J Thorac Crit Care Med


. 2021 Dec 31;27(4):10.7196/AJTCCM.2021.v27i4.185.
doi: 10.7196/AJTCCM.2021.v27i4.185. eCollection 2021.
Comparison of patients with severe COVID-19 admitted to an intensive care unit in South Africa during the first and second wave of the COVID-19 pandemic


U Lalla[SUP] 1 [/SUP], C F N Koegelenberg[SUP] 1 [/SUP], B W Allwood[SUP] 1 [/SUP], L N Sigwadhi[SUP] 2 [/SUP], E M Irusen[SUP] 1 [/SUP], A E Zemlin[SUP] 3 [/SUP], T E Masha[SUP] 4 [/SUP], R T Erasmus[SUP] 3 [/SUP], Z C Chapanduka[SUP] 5 [/SUP], H Prozesky[SUP] 6 [/SUP], J Taljaard[SUP] 6 [/SUP], A Parker[SUP] 6 [/SUP], E H Decloedt[SUP] 7 [/SUP], F Retief[SUP] 8 [/SUP], T P Jalavu[SUP] 3 [/SUP], V D Ngah[SUP] 2 [/SUP], A Yalew[SUP] 2 9 10 [/SUP], J L Tamuzi[SUP] 2 [/SUP], N Baines[SUP] 1 [/SUP], M McAllister[SUP] 2 [/SUP], A Zumla[SUP] 11 [/SUP], P S Nyasulu[SUP] 2 12 [/SUP]



Affiliations

Abstract

Background: The second wave of coronavirus disease 2019 (COVID-19), dominated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Beta variant, has been reported to be associated with increased severity in South Africa (SA).
Objectives: To describe and compare clinical characteristics, management and outcomes of COVID-19 patients admitted to an intensive care unit (ICU) in SA during the first and second waves.
Methods: In a prospective, single-centre, descriptive study, we compared all patients with severe COVID-19 admitted to ICU during the first and second waves. The primary outcomes assessed were ICU mortality and ICU length of stay (LOS).
Results: In 490 patients with comparable ages and comorbidities, no difference in mortality was demonstrated during the second compared with the first wave (65.9% v. 62.5%, p=0.57). ICU LOS was longer in the second wave (10 v. 6 days, p<0.001). More female admissions (67.1% v. 44.6%, p<0.001) and a greater proportion of patients were managed with invasive mechanical ventilation than with non-invasive respiratory support (39.0% v. 14%, p<0.001) in the second wave.
Conclusion: While clinical characteristics were comparable between the two waves, a higher proportion of patients was invasively ventilated and ICU stay was longer in the second. ICU mortality was unchanged.

Keywords: COVID-19; ICU; SARS-CoV-2; clinical characteristics; management; mortality; outcomes; waves.
 
Back
Top Bottom